Yuuji Murakami

Last Updated :2023/02/02

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medical), Associate Professor
Self-introduction
Radiation oncologist SPECIALITY Development of new techniques in Intensity Modulated Radiation Therapy Chemoradiotherapy for cancer of the digestive system Prediction of the outcomes of radiotherapy using AI & radiomics

Basic Information

Major Professional Backgrounds

  • 1995/05/16, 1996/03/30, Hiroshima University, Medical Hospital, Clinical Resident
  • 1996/04/01, 1998/02/28, Miyoshi Central Hospital, Department of Radiology,, Doctor
  • 1998/03/01, 2002/03/31, Hiroshimma city Asa hospital, Department of Radiology, Doctor
  • 2002/04/01, 2005/03/30, Hiroshima University, Medical Hospital, Clinical Fellow
  • 2005/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2011/03/31, Hiroshima University, Hospital, Assistant Professor
  • 2011/04/01, 2019/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2019/04/01, 2021/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2021/04/01, Hiroshima University, Graduate School of Biomedical & Health Sciences, Associate professor

Educational Backgrounds

  • Hiroshima University, Japan, 2003/04, 2007/05
  • Hiroshima University, Faculty of Medicine, Japan, 1988/04, 1995/03

Academic Degrees

  • M.D. Ph.D., Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medical Physicist
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Radiation science

Research Keywords

  • upper and lower digestive cancer
  • chemoradiotherapy
  • volumetric intensity modulated radiation therapy
  • radiotherapy
  • esophageal cancer
  • Head and neck cancer

Affiliated Academic Societies

  • Japanese society of medical oncology, 2020/05
  • American Society for Radiation Oncology

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Systemic Disease Control
  2. 2022, Undergraduate Education, Intensive, Practice for medical research
  3. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2022, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2022, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology
  6. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  7. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Radiation Oncology
  8. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  9. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  10. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  11. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology

Research Activities

Academic Papers

  1. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1), RADIATION ONCOLOGY, 17(1), 20220728
  2. A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning, BRITISH JOURNAL OF RADIOLOGY, 95(1135), 2022
  3. Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer, ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 134(1), 93-101, 202207
  4. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(5), 2791-2795, 202205
  5. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, RADIOTHERAPY AND ONCOLOGY, 166, 65-70, 202201
  6. Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 14(2), 115-122, 20220323
  7. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma, ADVANCES IN RADIATION ONCOLOGY, 2(2), 183-191, 2017
  8. Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review, JOURNAL OF GASTROINTESTINAL ONCOLOGY, 13(2), 885-897, 202204
  9. Baseline drift vector of multiple points on body surface using a near-infrared camera, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 45(1), 143-155, 202203
  10. Brachytherapy with Au-198 grains for cancer of the floor of the mouth: relationships between radiation dose and complications, ORAL RADIOLOGY, 38(1), 105-113, 202201
  11. Reirradiation Using Au-198 Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy, ANTICANCER RESEARCH, 42(1), 293-300, 202201
  12. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, Radiotherapy and Oncology, 166, 65-70, 20211125
  13. A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor, International Journal of Radiation Oncology*Biology*Physics, 111(3), 20211101
  14. Treatment outcomes of real-time intraoral sonography-guided implantation technique of Au-198 grain brachytherapy for T1 and T2 tongue cancer, JOURNAL OF RADIATION RESEARCH, 62(5), 871-876, 202109
  15. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning, BRITISH JOURNAL OF RADIOLOGY, 94(1124), 20210708
  16. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer, LARYNGOSCOPE, 131(7), 1522-1527, 20210701
  17. ★, Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using F-18-FDG PET Images, DIAGNOSTICS, 11(6), 20210601
  18. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 20210301
  19. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients, RADIATION RESEARCH, 195(3), 244-252, 20210301
  20. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 20210301
  21. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 20210101
  22. Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 80, 167-174, 20201201
  23. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 20201001
  24. What motivated medical students and residents to become radiation oncologists in Japan?-Questionnaire report by the radiotherapy promotion committee of JASTRO, JOURNAL OF RADIATION RESEARCH, 61(5), 727-732, 20200901
  25. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(7), 1250-1259, 20200701
  26. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers, ANTICANCER RESEARCH, 40(7), 4183-4190, 20200701
  27. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents, JOURNAL OF RADIATION RESEARCH, 61(4), 629-634, 20200701
  28. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers, JOURNAL OF RADIATION RESEARCH, 61(4), 554-562, 20200701
  29. Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection, RADIATION ONCOLOGY, 15(1), 20200601
  30. Evaluation of metal artefact techniques with same contrast scale for different commercially available dual-energy computed tomography scanners, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 43(2), 539-546, 20200601
  31. An overview of stereotactic body radiation therapy for hepatocellular carcinoma, EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 14(4), 271-279, 20200402
  32. Predictive gamma passing rate for three-dimensional dose verification with finite detector elements via improved dose uncertainty potential accumulation model, MEDICAL PHYSICS, 47(3), 1349-1356, 20200301
  33. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram, JOURNAL OF RADIATION RESEARCH, 61(2), 298-306, 20200301
  34. Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?, ANTICANCER RESEARCH, 39(8), 4279-4283, 201908
  35. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  36. Photon and electron backscatter dose and energy spectrum analysis around Lipiodol using flattened and unflattened beams, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 178-183, 201906
  37. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  38. Automatic calibration of an arbitrarily-set near-infrared camera for patient surface respiratory monitoring, MEDICAL PHYSICS, 46(3), 1163-1174, 201903
  39. Predictive gamma passing rate by dose uncertainty potential accumulation model, MEDICAL PHYSICS, 46(2), 999-1005, 201902
  40. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 59-65, 201902
  41. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 20190101
  42. Evaluation of raw-data-based and calculated electron density for contrast media with a dual-energy CT technique, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(5), 499-506, 2019
  43. Medium-term results of intensity modulated radiation therapy for patients with T1-3N0M0 prostate cancer, The journal of the Hiroshima medical association, 71(10), 663-668, 20181028
  44. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
  45. Clinical features of prostate-specific antigen bounce after I-125 brachytherapy for prostate cancer, JOURNAL OF RADIATION RESEARCH, 59(5), 649-655, 201809
  46. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, 201808
  47. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, 20180701
  48. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
  49. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), 20180611
  50. Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas, DIGESTIVE DISEASES AND SCIENCES, 63(6), 1605-1612, 201806
  51. ★, Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, Journal of Radiation Research, 59(5), 616-624, 201806
  52. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, World Journal of Surgery, 5(42), 1496-1505, 201806
  53. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
  54. Effect of secondary electron generation on dose enhancement in Lipiodol with and without a flattening filter, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(2), 211-217, 201803
  55. Relative biological effectiveness study of Lipiodol based on microdosimetric-kinetic model, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 46, 89-95, 201802
  56. Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(1), 50-56, 2018
  57. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(2), 84-90, 2018
  58. Automatic contrast medium extraction system using electron density data with dual-energy CT, BRITISH JOURNAL OF RADIOLOGY, 91(1090), 2018
  59. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, 201711
  60. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer, ANTICANCER RESEARCH, 37(5), 2709-2713, 201705
  61. Evaluation of beam modeling for small fields using a flattening filter-free beam, RADIOLOGICAL PHYSICS AND TECHNOLOGY, 10(1), 33-40, 201703
  62. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma., Adv Radiat Oncol, 2(2), 183-191, 201702
  63. Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408), JOURNAL OF RADIATION RESEARCH, 58(1), 149-154, 201701
  64. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans-arterial chemoembolization, MEDICAL PHYSICS, 44(1), 342-348, 201701
  65. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma, MEDICAL DOSIMETRY, 42(2), 97-103, 2017
  66. Absorbed dose and image quality of Varian TrueBeam CBCT compared with OBI CBCT, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1628-1633, 201612
  67. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, 201609
  68. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(4), 557-561, 201604
  69. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21(1), 88-94, 201602
  70. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, RADIOTHERAPY AND ONCOLOGY, 118(1), 60-64, 201601
  71. Preoperative coil embolization in patients with a replaced hepatic artery scheduled for pancreatectomy with splanchnic artery resection helps to prevent ischemic organ injury., Journal of Computer Assisted Tomography, 40(1), 172-176, 201601
  72. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, 2016
  73. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients` exposure dose, Reports of Practical Oncology & Radiotherapy, 21(5), 460-465, 2016
  74. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 21(5), 460-465, 2016
  75. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, 20151115
  76. ★, Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, 201510
  77. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), 20150611
  78. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, 201506
  79. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, 201506
  80. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, 201504
  81. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy, JOURNAL OF RADIATION RESEARCH, 56(2), 315-324, 201503
  82. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44(10), E273-E278, 201410
  83. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, 20140801
  84. Radiation-induced pyogenic vertebral osteomyelitis after re-irradiation for para-aortic lymph node metastases in a patient with cervical cancer, International Cancer Conference Journal, 3(4), 207-210, 2014
  85. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43(7), 717-727, 201307
  86. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69(6), 1499-1505, 201206
  87. ★, Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(3), 263-271, 201206
  88. Functional Image-Guided Radiotherapy Planning in Respiratory-Gated Intensity-Modulated Radiotherapy for Lung Cancer Patients With Chronic Obstructive Pulmonary Disease, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E663-E670, 20120315
  89. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(1), 48-54, 201202
  90. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima Journal of Medical Science, 60(4), 51-56, 20111201
  91. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Radiother Oncol., 118(1), 60-64, 2010
  92. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix., Int J Radiat Oncol Biol Phys, 75(2), 369-377, 20091001
  93. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001., Int J Radiat Oncol Biol Phys., 75(2), 357-363, 20091001
  94. Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced Non-Small-Cell lung cancer, Int J Clin Oncol,, 14(5), 408-415, 20091001
  95. Results of the 1999-2001 Japanese Patterns of Care Study for Patients Receiving Defintive Radiation Theraphy without Surgery for Esophageal Cancer, Japanese journal of clinical oncology, 37(7), 493-500, 20070723
  96. ★, Evaluation of the basic properties of the BANGkitTM gel dosimeter, Physics in Medicine and Biology, 52(8), 2301-2311, 20070403
  97. ★, Evaluation of the basic properties of the BANGkit? gel dosimeter, Physics in Medicine and Biology= Institute of Physics, 52, 2301-2311, 20070403
  98. Preoperative portal vein embolization with a mixture of gelatin sponge and lodized oil: Efficacy and safety, Acta Radiologica, 47(10), 1022-1028, 20061201
  99. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?, International radiation oncology biology and physics, 66(2), 483-491, 20061001
  100. Diffuse cerebral white matter T2-weighted hyperintensity: a new finding of general paresis., Acta Radiologica, 47, 609-611, 20060701
  101. Potential benefits of volumetric modulated arc therapy to reduce the incidence of >= grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12), 1729-1735, 202112

Publications such as books

  1. 2020/09, Guideline for radiotherapy treatment planning, 2020, September, Textbook, Joint work, 日本語, ISBN: 9784307071161, 440, 139-144
  2. 2016/09/15, Guideline for radiotherapy treatment planning, 2016, September, Textbook, Joint work, 日本語, 978-4-307-07104-8, 408, 119-123

Invited Lecture, Oral Presentation, Poster Presentation

  1. Oral Session 2 Head and Neck, Yuji Murakami, JSMO2022, 2022/02/17, With Invitation, English
  2. Potential benefits of volumetric modulated arc therapy to reduce the incidence of grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients., Imano N, Kimura T, Kawahara D, Kubo K, Takeuchi Y, Saito A, Nishibuchi I, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  3. Survey of IMRT in Japan., Nagata Y, Ozawa S, Kawahara D, Miura H, Nakao M, Murakami Y, Nishibuchi I, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  4. Interstitial brachytherapy for locally advanced tongue cancer: Analysis of the long-term Treatment results for survival and complications., Takeuchi Y, Imano N, Nishibuchi I, Kubo K, Murakami Y, Saito A, Kawahara D, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  5. A prediction model for para-aortic lymph node metastasis in cervical cancer by radiomics analysis using pre-treatment MRI images of the primary tumor., Nishibuchi I, Kawahara d, Kawamura M, Kubo K, Imano N, Takeuchi Y, Saito A, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  6. Tolerances of CT number to mass density table for adaptive helical tomotherapy with MVCT, Tsunemine S, Ozawa S, Nakao M, Miura H, Saito A, Kawahara D, Onishi Y, Onishi T, Okawa F, Terai A, Ueda R, Hashiguchi T, Enomoto N, Yamasaki H, Maruta T, Murakami Y, Nagata Y, The 9th Korea-Japan Joint Meeting on Medical, 2021/09/09, Without Invitation, English
  7. Current update and perspective of the combination of immunotherapy and radiotherapy, Yuji Murakami, JSMO2022, Without Invitation, English
  8. Association between acute toxicities of chemoradiotherapy and chromosomal aberrations in peripheral blood lymphocytes in esophageal cancer patients, Imano N, Nishibuchi I, Kawabata E, Kinugasa Y, Sakai C, Ishida M, Akita T, Kimura T, Murakami Y, Nagata Y, Tashiro S, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English
  9. Survey of stereotactic body radiation therapy in Japan, Nagata Y, Ozawa S, Nakao M, Kawahara D, Kimura T, Murakami Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English
  10. Temporal change and risk factor of esophageal stenosis after salvage radiotherapy for superficial esophageal cancer with non-curative endoscopic submucosal dissection, Murakami Y, Kawahara D, Imano N, Takahashi I, Takeuchi Y, Nishibuchi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  11. A machine learning model with radiomics based on PET images to predict pathological response by neoadjuvant chemoradiotherapy for esophageal cancer., Murakami Y, Kawahara D, Imano N, Takahashi I, Takeuchi Y, Nishibuchi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  12. Aperture area in IMRT studied via accumulated dose uncertainty potential, Shiba E, Saito A, Furumi M, Kawahara D, Miki K, Murakami Y, Ohguri T, Ozawa S, Tsuneda M, Yahara K, Nishio T, Korogi Y, Nagata Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, (American Association of Physicists in Medicine
  13. Novel index to predict non-hematologic acute toxicities caused by chemoradiotherapy in esophageal cancer patients., Imano N, Nishibuchi I, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Kimura T, Murakami Y, Tashiro S, Nagata Y, 2020/05/15, Without Invitation, Japanese
  14. A new work-flow of appropriate planning for VMAT using patient specific template with geometrical ideal dose distribution., Miki K, Saito A, Kawahara D, Nakashima T, Nishibuchi I, Kimura T, Murakami Y, Nagata Y:, 2020/05/15, Without Invitation, Japanese
  15. Association between Severe Gastrointestinal Toxicity and Molecular Targeted Therapy in Patients Received Radiotherapy for Metastatic Bone Tumor or Myeloma., Murakami Y 1, Ishikawa K 2, Sakayauchi T 3, Itasaka S 4, Negoro Y 5, Jingu K 6, Nishimura Y2 , Nagata Y 1, Ogawa K 7., 61st Annual meeting of American society of radiation oncology, 2019/09/16, Without Invitation, English
  16. Current Status of Radiotherapy for Esophageal Squamous Cell Carcinoma In Japan, Yuji Murakami, 2019 Health Science Symposium with Taichung Veterans General Hospital, 2019/07/26, Without Invitation, English, Hiroshima University Hospital, Hiroshima
  17. IMRT for prostate, Murakami Y, HICARE/IAEA International Training Course on Advanced Radiation Therapy (IAEA-RCA Regional Training Course), 2019/02/18, Without Invitation, English, HICARE/IAEA
  18. A Simplified Three-Isocenter VMAT for Craniospinal Irradiation, Takahashi I, Adachi Y, Imano N, Takeuchi Y, Nishibuchi I, Miki K, Saito, A , Kimura T, Murakami Y, Nagata Y, European Society for Radiotherapy and Oncology meets Asia 2018(ESTRO), 2018/12/07, Without Invitation, English, European Society for Radiotherapy and Oncology, Singapore
  19. A simplified three-isocenter VMAT for craniospinal irradiation., Takahashi I, Imano N, Takeuchi Y, Nishibuchi I, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  20. Comparison of stereotactic body radiation therapy combined with or without transcatheter arterial chemoembolization for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., Kimura T, Doi Y, Aikata H, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo K, Murakami Y, Awai K, Chayama K, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  21. The efficacy and tolerability of S-1 in the treatment of preoperative chemoradiotherapy for locally advanced rectal cancer., Imano N, Nishibuchi I, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  22. Salvage radiation therapy with elective nodal irradiation for superficial esophageal cancer after incomplete endoscopic resection., Nishibuchi I, Murakami Y, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  23. Long-Term Results of Neoadjuvant Chemoradiotherapy + Esophagectomy for Resectable Locally Advanced Esophageal Cancer, Yuji Murakami, 2018/10/13, Without Invitation, Japanese, JASTRO, Kyoto
  24. Current Status of Radiotherapy for Esophageal Cancer, Yuji Murakami, The National Radiation Oncology Meeting on Advanced Radiation Oncology Technologies in Mongolia, 2018/09/18, With Invitation, English, National cancer center Mongolia, Ulaanbaatar, Mongolia
  25. The Efficacy and Tolerability of S-1 in the Treatment of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer., Imano N, Murakami Y, Nishibuchi I, Adachi Y, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., The 3rd Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2018/09/06, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Bali, Indonesia
  26. Biological dose enhancement using lipiodol in liver SBRT after TACE., Kawahara D, Nakano H, Ozawa S, Saito A, Kimura T, Tsuneda M, Hioki K, Masuda H, Ochi Y, Nakashima T, Ohno Y, Murakami Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  27. Structure and aperture-based robustness estimation for volumetric modulated arc therapy., Mori M, Saito A, Kawahara D, Miki K, Murakami Y, Nakashima T, Okumura T, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  28. Predictive gamma passing rate based on dose uncertainty for head-and-neck and prostate IMRT., Shiba E, Saito A, Tsuneda M, Furumi M, Yahara K, Ohguri T, Murakami Y, Nishio T, Korogi Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  29. Tips & Pitfall in H&N VMAT, Yuji Murakami, 2018/06/02, With Invitation, Japanese, Shizuoka Japan
  30. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Yuji Murakami, Yasushi Nagata, Tomoki Kimura, Ikuno Nishibuchi, Takeo Nakashima;, Gastrointestinal Cancers Symposium 2018, 2018/01/19, Without Invitation, English, American society of clinical oncology, San Francisco USA
  31. Current status of radiotherapy for brain metastasis, Yuji Murakami, Hiroshima Gamma Knife Conference, 2018/01/10, With Invitation, Japanese
  32. Current status and future perspective of IMRT in Hiroshimauniversity hospital, Yuji Murakami, Hiroshima university hospital oncology meeting, 2018/01/10, Without Invitation, Japanese
  33. Long-term results of definitive chemoradiotherapy for elderly patients with esophageal cancer, Nishibuchi I, Murakami Y, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Wadasaki K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting (ASTRO), 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology, San Diego, USA
  34. Long-term results of stereotactic body radiation therapy for patients with small hepatocellular carcinoma inligible for resection or ablation therapies., Kubo K, Kimura T, Aikata H, Takahashi S, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Chayama K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting, 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology 59th annual meeting, San Diego USA
  35. Repeated stereotactic body radiotherapy for intra-hepatic recurrent hepatocellular carcinoma., Kimura T, Hioki K, Aikata H, Kubo K, Takahashi S, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Chayama K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting, 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology 59th annual meeting, San Diego USA
  36. Educational Lecture 1 Head & Neck cancer, 2017/09/09, With Invitation, Japanese
  37. Head & Neck, Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, English, Kyoto
  38. Definitive radiotherapy for para aortic lymph node metastasis of cervical squamous cell carcinoma., I. Nishibuchi., K. Wadasaki, Y. Kaneyasu, N. Imano, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, Y. Murakami, T. Nishio, Y. Nagata., The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, English, Kyoto
  39. Role of chemoradiation therapy in multi-modality treatment for resectable esophageal cancer., Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, Japanese, Kyoto
  40. Current status of the education of Radiation Oncology, Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, Japanese, Kyoto
  41. Treatment outcomes of chemoradiotherapy for limited-stage small cell lung cancer., I. Takahashi, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, T. Nishio, Y. Nagata, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, Japanese, Kyoto
  42. Treatment results of definitive chemo-radiation therapy in patients with cervical esophageal cancer., Y. Takeuchi, Y. Murakami, I. Takahashi, I. Nishibuchi, T. Kimura, A. Saito, T. Nishio, Y. Nagata., The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, Japanese, Kyoto
  43. Impact of expiratory tumor motion patterns on dose volume histogram in treatment phase selection of respiratory gating radiation therapy for lung cancer, N. Imano, I.Nishibuchi, T. Kimura, T. Nakashima, T. Okumura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  44. Salvage radiotherapy for superficial esophageal cancer after incomplete endoscopic resection, I. Nishibuchi, Y. Murakami, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, T. Nishio, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  45. A simplified Three-Isocenter IMRT for craniospinal irradiation to minimize planning and treatment time, I. Takahashi, K. Kashiwado, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  46. Combined ventilationand perfusion imaging correlates with the dosimetric parameters of radiatoin pneumonitis in radiation therapy planning for lung cancer., T. Kimura, T. Nakashima, A. Saito, Y. Takeuchi, I. Takahashi, I. Nishibuchi, Y. Murakami, T. Nishio, Y. Nagata., Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, Japanese, American Society for Radiation Oncology, Boston, MA, USA
  47. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy, Y. Murakami, Y. Takeuchi, I. Takahashi, I. Nishibuchi, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Horoshima
  48. Evaluation of adverse events in Atomic Bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Y. Doi, Murakami, M. Kenjo, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hirohima
  49. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for ablation therapies., T. Kimura, H. Aikata, I. Takahashi, Y. Takeuchi, I. Nishibuchi, Y. Murakami, K. Awai, K. Chayama, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima
  50. Educational lecture IMRT for head and neck cancer, Y. Murakami, Thw 75th annual meeting of Japanese Radiation Society, 2016/04/17, With Invitation, English, Japanese Radiation Society
  51. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy., Murakami Y., Kawabata H., Takeuchi Y., Nishibuchi I.,Okabe T., Kenjo M., Kimura T., Nagata Y., JASTRO 28th annual meeting, 2015/11/19, Without Invitation, English, JASTRO, Gunma Japan
  52. Incidence and clinical features of metachronous esophageal cancer after definitive radiation therapy for esophageal cancer., Murakami Y, Kawabata H, Takeuchi Y, Doi Y, Okabe T, Kenjo M, Kimura T, Nagata Y., American Society for Radiation Oncology 57th annual meeting(ASTRO), 2015/10/18, Without Invitation, English, American Society for Radiation Oncology, San Antonio,Texas, USA
  53. Preliminary Outcomes of Induction Chemotherapy+VMAT with Concurrent Chemotherapy for Stage IVA/IVB oro- and Hypopharyngeal Cancer, Yuji Murakami, Tomoki Kimura, Katsumaro Kubo, Hiromi Sakaguchi, Nobuki Imano, Hideo Kawabata, Yoshiko Doi, Masahiro Kenjo, Yasushi Nagata, International congress of Radiation Research(ICRR), 2015/05/25, Without Invitation, English, KYOTO
  54. VMAT for head and neck cancer, Y. Murakami, HICARE/IAEA International Training Course, 2015/01/19, Without Invitation, English, HICARE/IAEA, Hiroshima, Japan
  55. 直腸癌に対する術前化学放射線療法の検討, 川畑秀雄, 村上祐司, 久保克麿, 坂口弘美, 今野伸樹. 土井歓子. 岡部智行. 権丈雅浩. 木村智樹. 永田 靖, 日本放射線腫瘍学会総会, 2014/12, Without Invitation, Japanese
  56. IVA/IVB期中下咽頭癌に対する導入化学療法後化学放射線治療の初期経験, 日本放射線腫瘍学会学術大会, 2014/12, Without Invitation, Japanese, YOKOHAMA
  57. 頭頸部癌に対する導入化学療法後化学放射線療法の検討, 2014/10, Without Invitation, Japanese
  58. Results Of Neoadjuvant Chemoradiotherapy Followed By Surgery For Locally Advanced Esophageal Squamous Cell Carcinom, Y. Murakami, N. Imano, Y. Doi, T. Okabe, M. Kenjo, T. Kimura, J. Hihara, Y. Nagata, The American Society for Radiation Oncology 56th annual meeting(ASTRO), 2014/09/15, Without Invitation, Japanese, SanFrancisco, USA
  59. 上咽頭癌に対する強度変調回転照射の短期成績, 日本医学放射線学会総会, 2014/04, Without Invitation, English, 日本医学放射線学会
  60. 新規治療システムにおける前立腺癌に対するsingle arc VMATの検討, 村上祐司, 中島健雄, 河原大輔 奥村拓朗, 今野伸樹, 勝田 剛, 土井歓子, 岡部智行, 権丈雅浩, 兼安祐子, 木村智樹, 小澤修一, 永田靖, 日本高精度放射線外部照射研究会, 2014/02, Without Invitation, Japanese, 日本高精度放射線外部照射研究会
  61. バリアン新治療システムの使用感~TrueBeam と Eclipse v11.0の強度変調放射線治療における臨床的有用性について~, YUJI MURAKAMI, 2014 Varian Seminar, 2014/02, With Invitation, Japanese, Varian medical

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research for Innovative Cancer Control, 2015/04/01, 2016/03/31
  2. KAKENHI, 2014, 2016
  3. KAKENHI, Development of Functional Image-Guided Radiotherapy Planning inIntensity-Modulated Radiation Therapy (IMRT) for Lung Cancer, 2010, 2012
  4. KAKENHI, Development of a new Stereotactic Body Radiation Therapy (SBRT) and Intensity Modulated Radiation therapy (IMRT) technique using an integrated Image Guide Radiation Therapy (IGRT) system, 2010, 2012
  5. KAKENHI, 2009, 2010
  6. Health and Labour Sciences Research Grants, 2014/05/01, 2015/03/31
  7. KAKENHI, 2015, 2018
  8. Practical Research for Innovative Cancer Control , 2016/04/01, 2017/03/31
  9. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2019, 2021

Social Activities

Organizing Academic Conferences, etc.

  1. 2022/11, 2022/11
  2. 2021/03, 2021/03

Other Social Contributions

  1. 2019 Health Science Symposium with Taichung Veterans General Hospital, Current Status of Radiotherapy for Esophageal Squamous Cell Carcinoma in Japan, 2019/07/26, Hiroshima Japan, Lecturer, Meeting or assembly, Researchesrs
  2. HICARE-IAEA seminar, IMRT for Localized Prostate Cancer, HICARE-IAEA, 2019/02/18, Hiroshima Japan, Lecturer, Seminar or workshop, Researchesrs

History as Peer Reviews of Academic Papers

  1. 2020, JOrunal of radiation research, Others, reviewer, 2
  2. 2020, Esophagus, Others, Reviewer, 1
  3. 2020, Japanese journal of clinical oncology, Others, Reviewer, 1
  4. 2016, The journal of radiation research, Others, reviewer, 8
  5. 2015, The Journal of Radiation Research, Others, Reviewer, 2
  6. 2014, The Journal of Radiation Research, Others, Reviewer, 3